Standardized Methodology Developed to Evaluate Long-Term Anti-VEGF Outcomes in Diabetic Macular Edema
Long-Term Outcomes and Predictors of Response to Anti-VEGF Therapy for Diabetic Macular Edema in Clinical Practice.
Abstract
Protocol outlines standardized methodology for evaluating 24-month anti-VEGF therapy effectiveness and safety in diabetic macular edema (DME) using real-world data.